CENCORA INC (COR) Stock News

COR March 21st Options Begin Trading

Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower

JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.

Cencora Announces Date and Time for First Quarter Fiscal 2025 Earnings Release

COR Makes Bullish Cross Above Critical Moving Average

Cencora Completes Acquisition of Retina Consultants of America

Looking Into Cencora's Recent Short Interest

Cencora Closes $1.8 Billion Senior Notes Offering

Cencora Prices $500 Million 4.625% Senior Notes Due 2027, $600 Million 4.850% Senior Notes Due 2029 and $700 Million 5.150% Senior Notes Due 2035

McKesson Stock Gets A RS Rating Lift To 75

The Relative Strength (RS) Rating for McKesson stock jumped into a new percentile Wednesday, as it got a lift from 70 to 75.

Cardinal Health Stock Sees IBD RS Rating Improve To 71

In a welcome move, Cardinal Health stock saw its Relative Strength (RS) Rating rise from 65 to 71 on Friday.

Cencora Reports Fiscal 2024 Fourth Quarter and Year End Results

Cencora Advances Specialty Leadership Through Acquisition of Retina Consultants of America

Cencora Expands Enterprise Leadership Team with Two Senior Appointments

Walgreens Stock Rally: 4 Reasons WBA Could Be a Strong Buy

Walgreens Boots Alliance (WBA) is down 60% from its 52-week high, but improving earnings, cost cuts, and a 9.27% dividend yield signal potential recovery.

Cencora Announces Date and Time for Fourth Quarter Fiscal 2024 Earnings Release

Why Walgreens Boots Alliance Fell Another 22% in August

The retail pharmacy giant faces ever-mounting headwinds.

Is the Temu Hype Warranted?

School's in and we've also got a look at the challenges teachers face while saving for retirement.